Neuromelanin Magnetic Resonance Imaging of Substantia Nigra in Patients with Parkinson disease dementia (PDD), Alzheimer disease (AD) and Age-matched controls.
Won-Jin Moon 1 , Ju Yeon Park 2 , Jin Woo Choi 2 , Yeon Sil Moon 3 , Seol-Heui Han 3 , Ki-Chang Kwak 4 , and Jong-Min Lee 4
Department of Radiology, Konkuk University
School of Medicine, Seoul, Seoul, Korea,
University School of Medicine, Seoul, Korea,
of Neurology, Konkuk University School of Medicine,
of Biomedical Engineering, Hanyang University, Seoul,
Volumetric measurement of T1 hyperintense substantia
nigra can be a useful imaging marker for evaluating
neuromelanin loss in neurodegenerative diseases
including AD and PDD.
This abstract and the presentation materials are available to members only;
a login is required.